Table 2.
Multivariable analyses using the MCID of the FMA-UE as the outcome measure according to stroke phase.
Subacute phase | Chronic phase | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Baseline characteristics | Unstandardized coefficient | Odds ratio | 95% CI | P-value | Unstandardized coefficient | Odds ratio | 95% CI | P-value | ||
Time since onset | −0.014 | 0.99 | 0.97 | 1.00 | 0.043* | −0.008 | 0.99 | 0.98 | 1.00 | 0.066† |
HMS | 0.451 | 1.57 | 1.01 | 2.44 | 0.045* | 0.497 | 1.65 | 0.95 | 2.85 | 0.076† |
Constant | −0.520 | 0.60 | 0.543 | −0.078 | 0.93 | 0.958 |
MCID, minimal clinically important difference; FMA-UE, Fugl-Meyer Assessment-Upper Extremity; CI, confidence interval; HMS, Hand Movement Scale.
P < 0.05;
P < 0.1 in the multivariable analysis.